Diary of a Private Investor

Bioventix

Two keepers and the one that got away

Happy Friday everyone! Without wishing to tempt fate while there are still a few hours trading to go before markets close but this week looks set to deliver my largest portfolio gain of the year so far. Sometimes market exuberance can be a wonderful thing so long as one is able to find a chair […]

, , , , , ,

Q2 Rebalancing Update

In my last article I highlighted some rebalancing I had planned for my portfolio, including dividend reinvestment. This brief article provides an update on those changes along with commentary: Bioventix (BVXP) – top sliced. This remains my largest holding but I felt it prudent to top slice in order to lock in some of the […]

, , , , , , , , , , , , , , , , , , , , , , , , , ,

Making Hay While The Sun Shines – Q1 2017 Portfolio Review

The Headlines – Overall, my portfolio is up by 11.51% since the start of 2017 (including reinvested dividends) – I currently have 32 holdings of which 22 are profitable positions and 10 are running at a loss, year-to-date (excluding dividends) – A total of 116 trades during the quarter. However, this is a little misleading […]

, , , , , , , , , , , , , , , , , , , , , , , , , ,

Six of the Best Growth Shares in 2017

Continuing this seasonal “Six of the Best” series, today I’ll be sharing my favourite growth shares for the year ahead. Every growth share is only a profit warning away from becoming an investment dog of course and no more so is this the case than with smallcaps. At the same time, smallcaps also provide an […]

, , , , , , , , , , , ,

Three strikes in my portfolio and a great offer from Research Tree

Those 7am RNS announcements can be nerve racking until you have seen whether one of your holdings is announcing good or bad news. This morning I thought I had hit the jackpot when three of my holdings announced excellent news: Bioventix (BVXP) announced final results today for the year ended 30th June 2016 – highlights: […]

, , , , , , , , , ,

Share Watch: Bioventix (BVXP)

The folks at ShareSoc very kindly recorded the presentation made by Peter Harrison, CEO Bioventix, at their Richmond Supper this week. It is a very useful presentation for investors wanting to learn more about the BVXP business model, the predictability of their income streams and how they manage to achieve this without patent protection. BVXP […]

, , ,

Portfolio Commentary Part Two – Compound Growth Strategy

Over the past week I have published various portfolios; Focused Income, Compound Growth and Special Situations which combined, make up my overall equity portfolio. I have also launched an ISA portfolio to reflect and track how I invested this years’ allowance. The main reasons for dividing my overall holdings into different strategies were outlined in […]

, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

Pre-Holiday Update – BVXP, SRT, BKG, PHP, GVC

A few updates from my holdings over the past couple of weeks: Bioventix (BVXP.L) In my view, the company issued a positive half-yearly report on 21st March but the shares have subsequently fallen. Turnover up 23%, pre-tax profit up 33%, post tax profit up 31%, dividend up 50% and yet the shares are down. This […]

, , , , , , , , , , , , , ,